Navigation Links
Driver of anthrax toxicity could lead to late-stage therapy

A study in the March 24 Cell reports the discovery of a gene that drives anthrax bacteria's toxic effects. The gene could offer a potential new target for countermeasures against the lethal toxin, according to the researchers.

Such therapies might have the potential to protect against anthrax during the late stages of the disease, after antibiotics have lost their therapeutic value, they added.

The team found that human cells deficient in the so-called LDL receptor-related protein (LRP6) become resistant to anthrax toxin. Furthermore, antibodies against LRP6 protected cells from anthrax toxicity, reported study authors Wensheng Wei and Stanley Cohen of the Stanford University School of Medicine in collaboration with others at Stanford and the National Institutes of Health. The level of anthrax protection afforded by the antibodies rose with increasing dose.

Anthrax is a lethal disease of humans and other animals caused by the spore-forming bacteria Bacillus anthracis, which has been the focus of biological interest and bioterrorism concern. The virulence of the bacteria depends on separate complexes formed by interaction of a carrier protein, protective antigen, with lethal and edema factors responsible for the toxic effects and swelling that impairs the host's immune response.

In the current study, the researchers inactivated genes randomly in human cells. They then examined the mutated cells for resistance to anthrax toxin in an effort to identify host genes that have important roles in infection, with the hope of finding possible new targets for therapies aimed at the host instead of the bacteria. The method allows for the identification of required host cell genes without pre-conceptions about their potential to play a role, the study authors said.

The study revealed that LRP6 acts as a co-receptor, enabling cells to take up anthrax toxin through its interactions with two distinct cell- surface proteins earlier shown to bi
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Scientists seek answers on what activates deadly anthrax spores
2. Antibodies from plants protect against anthrax
3. Defensins neutralize anthrax toxin
4. Critical step traced in anthrax infection
5. US Army plans to bulk-buy anthrax
6. New antibody shows promise as cure for anthrax
7. Effective, safe anthrax vaccine can be grown in tobacco plants
8. UCSD study finds anthrax toxins also harmful to fruit flies
9. Scientists design potent anthrax toxin inhibitor
10. Newly discovered protein kills anthrax bacteria by exploding their cell walls
11. Combating anthrax: Results of study published this month as researchers look for a better vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Driver anthrax toxicity could lead late stage therapy

(Date:9/23/2014)... body forms new tissues during the healing process, ... other. For years, scientists believed this communication happened ... Mellon University and the University of Pittsburgh have ... is equally if not more crucial. The findings, ... Proceedings of the National Academy of Sciences , ...
(Date:9/23/2014)... Research by Rice University scientists who are fighting a ... be a clinician,s most powerful ally. , "Recent research ... cyberwarfare against the immune system, and we studied the ... how we might turn the tables on cancer," said ... this week in the Early Edition of the ...
(Date:9/23/2014)... identified a gene mutation that causes aplastic anemia, ... marrow fails to produce normal amounts of blood ... had blood disorders, the researchers discovered a defect ... with crucial roles in normal cell function. , ... molecular-based treatments that bypass the gene defect and ...
Breaking Biology News(10 mins):The mechanics of tissue growth 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3Gene mutation discovered in blood disorder 2
... Holy Grails of nanotechnology, but nature has been producing ... scientists has taken a unique look at how thousands ... clusters that direct cell movement to select chemicals in ... complex periodic patterns in biological systems can be generated ...
... Alexopoulos Prize will be given to Dr. Brian Shaw, Texas ... 29 in Snowbird, Utah. The honor based on ... known as the Outstanding Early-Career Mycologist Award of the Mycological ... and four review papers in 12 years. Both the National ...
... This release is available in Spanish . ... technique consisting of the induction of neuronal degeneration neuronal for ... helpful for the study of retinitis pigmentosa (RP), a group ... than one million persons a year all over the world. ...
Cached Biology News:Spontaneous assembly 2Spontaneous assembly 3Spontaneous assembly 4Work in mice will contribute to the study of hereditary diseases that lead to blindness 2
(Date:9/23/2014)... 2014 Erlab , the expert ... 1968 and Burdinola, supplier of laboratory furniture solutions, announce ... fume hood. , By integrating Erlab’s ... will now offer an innovative solution utilizing the patented ... chemicals, best-in-class detection technology, and communication for security and ...
(Date:9/23/2014)... , Sept. 23, 2014 Research ... "Proteomics Markets for Research and IVD Applications ... report to their offering. ... proteomics applications, both in their research use and ... including the study of the structure and function ...
(Date:9/23/2014)... 2014 For the fifth time since 2006, ... of the fastest-growing companies. , “We’re so proud that ... by Inc. Magazine,” ExakTime CEO Tony Pappas said. , ExakTime ... a three-year growth rate of 61 percent from 2010 to ... more than 40 percent. , Pappas cited strong performance in ...
(Date:9/23/2014)... California (PRWEB) September 23, 2014 ... biotechnology is gaining steady popularity the world over, ... breeding techniques. Growth in the marketplace is expected ... (GM) crops in developing countries. Several sub-Saharan countries ... under-nourished population, have already implemented genetically engineered crop ...
Breaking Biology Technology:Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 2Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 4ExakTime Makes Inc. 5000 List for the Fifth Time 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
... BOCA RATON, Fla., Oct. 30 Nabi,Biopharmaceuticals (Nasdaq: ... Group (ISS) and Glass Lewis & Co., two ... that stockholders of the,Company vote "FOR" the Company,s ... certain Corporate Shared Services assets to Biotest,Pharmaceuticals Corporation, ...
... (OTC,Bulletin Board: NNLX) a nano-biotechnology company announces the date ... meeting will take place at 1 PM on 12/28/07 ... A call-in number will be provided for,questions to management. ... days prior to the meeting. Shareholders of record as ...
... 30 /PRNewswire-FirstCall/ - ICBS Limited,(PINKSHEETS: ICBM), today announced ... Bacteria Bank Ltd., is a Bio medical ... for use in medical research, located,in Montreal Canada. ... a world,renowned bacteriologist. Dr. Karl Weiss is ...
Cached Biology Technology:RiskMetrics Group (ISS) and Glass Lewis & Co. Support Nabi Biopharmaceuticals' Proposed Asset Sale 2RiskMetrics Group (ISS) and Glass Lewis & Co. Support Nabi Biopharmaceuticals' Proposed Asset Sale 3NanoLogix Inc. Sets Date for Annual Shareholder Meeting and Provides Shareholder Update 2NanoLogix Inc. Sets Date for Annual Shareholder Meeting and Provides Shareholder Update 3ICBS acquires 30% interest in Bacteria Bank Ltd. 2
...
... Continuing a tradition of progressive centrifuge design ... series. The Centra-CL3 and Centra-CL3R (refrigerated) general ... laboratory., Quality Control Over Sample Preparation ... lock up to 99 protocols and has ...
PP2B-Abeta (C-20)...
... 8-iso PGE2 is one of several isoprostanes ... is a potent renal vasoconstrictor in the rat. ... with IC50 values of 0.5 and 5 µM, ... the rat at a concentration of 4 mg/kg/min, ...
Biology Products: